ARCHIVES

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Herceptin With Chemo Increases Survival In Early-Stage Breast Cancer, Study Finds

December 30, 2005

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009